3175 results for «439»
3175 results
Left main coronary interventions from basics to stenting techniques
15 May 2024 – From EuroPCR 2024
These EuroIntervention papers changed my practice!
15 May 2024 – From EuroPCR 2024
Bifurcation lesion, interactive case discussion
15 May 2024 – From EuroPCR 2024
Has the 2023 ESC-EACTS guideline review on left main changed my practice?
15 May 2024 – From EuroPCR 2024
Watch this session if you wish to learn why the 2019 guidelines were revised, how to apply the updated recommendations in clinical settings through case examples, and the criteria for selecting patients with left main stenosis for PCI versus CABG.
The session includes detailed presentations on...
An image is worth a 1,000 words
15 May 2024 – From EuroPCR 2024
Valve-in-valve
15 May 2024 – From EuroPCR 2024
TAVI Hotline: new devices, new approaches
15 May 2024 – From EuroPCR 2024
The taboo of mental health in the cathlab
15 May 2024 – From EuroPCR 2024
This session aims to address the impact of the stressful cathlab environment on the mental health of healthcare professionals. It explores the unique challenges faced in the cathlab, the role of communication in affecting staff mental health, and strategies to build a more resilient workforce. The...
Equity in STEMI management: bridging gaps in STEMI care for women
15 May 2024 – From EuroPCR 2024
This joint session with the Stent - Save a Life! initiative focuses on the unique challenges in STEMI diagnosis and management for women. It explores different pathological processes resulting in STEMI and STEMI mimics in women, and discusses optimal management techniques. The session features perspectives from...
TAV-in-TAV in complex situations
16 May 2024 – From EuroPCR 2024
This session comprises selected EuroPCR 2024 Clinical Case submissions focused on TAVI-in-TAVI procedures in complex situations. It covers various case presentations and discussions, including re-do TAVI with the risk of acute coronary obstruction, expanding possibilities in TAVR-in-TAVR with the mid-leaflet implantation technique, transcatheter valve-in-valve in self-expanding...
How to approach isolated ostial left circumflex artery lesion?
15 May 2024 – From EuroPCR 2024
Thanks to this session, explore the role of imaging and physiology in assessing ostial circumflex lesions, examine treatment options for the ostial left circumflex artery, and discuss optimization strategies to enhance long-term outcomes.
BRIGHT-4 – Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial
07 Nov 2022
Nicola Ryan provides her take on the BRIGHT-4 study, which was presented during AHA 2022 in Chicago, & simultaneously published in the Lancet.
This study was a randomised control trial designed to assess if bivalirudin plus a high dose infusion for 2-4 hours post PPCI was superior to unfractionated...
Author
Three-year results of HOST-POLYTECH-ACS RCT comparing durable- vs. degradable-polymer DES
30 Aug 2023
Alex Sticchi provides his take on the 3-year results of HOST-POLYTECH-ACS RCT which were presented by Hyo-Soo Kim during the ESC 2023 congress in Amsterdam.
Author
NEO-MINDSET: Early withdrawal of aspirin after percutaneous coronary intervention for acute coronary syndrome
02 Sep 2025
Daniele Giacoppo reports and provides his perspective on the main results of the ambitious NEOMINDSET trial, presented by Pedro Lemos from the Hospital Israelita Albert Einstein, São Paulo, Brazil, during a Late Breaking Trials session at the ESC Congress 2025 in Madrid, and simultaneously published in the New...
Author
Evidence base: A description of the key, so far published, studies in the space of drug coated balloons
23 Jan 2025
Authored by Hector Garcia-Garcia and Jorge Sanz-Sanchez, this article examines pivotal randomized clinical trials on drug-coated balloons in coronary artery disease. It highlights their role in managing in-stent restenosis, de novo small vessel lesions, and large vessel lesions while exploring future directions through ongoing trials.
Author
Author
